BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11593731)

  • 1. [Acceptable definition of peripheral early lung cancer].
    Morita R; Suga M; Nakamura S; Kaneko K; Kyo S
    Kyobu Geka; 2001 Oct; 54(11):938-41. PubMed ID: 11593731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
    Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
    J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
    Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor dimension and prognosis in surgically treated lung cancer: for intentional limited resection.
    Nonaka M; Kadokura M; Yamamoto S; Kataoka D; Kunimura T; Kushima M; Horichi N; Takaba T
    Am J Clin Oncol; 2003 Oct; 26(5):499-503. PubMed ID: 14528079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Result of surgical treatment to early stage peripheral non-small cell lung cancer].
    Yoneda S; Okabayashi K; Kawahara K; Iwazaki A; Yoshinaga Y; Yamamoto S; Ikeda K; Hamatake D; Takahashi M; Katoh F; Hayashi H; Yamaguchi R; Yoshida Y; Shirakusa T
    Kyobu Geka; 2001 Oct; 54(11):932-7. PubMed ID: 11593730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
    Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent survival in a subgroup of patients with intrapulmonary metastasis of lung cancer.
    Nakajima J; Furuse A; Oka T; Kohno T; Ohtsuka T
    Ann Thorac Surg; 1996 Jan; 61(1):158-62; discussion 162-3. PubMed ID: 8561544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment of the so-called "galloping type" small size carcinoma of the lung].
    Namikawa S; Mizumoto T; Kusagawa H; Hiraiwa T; Kimura M; Kusagawa M
    Kyobu Geka; 1991 Jan; 44(1):12-7. PubMed ID: 1645417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cases of death after surgery for pathologic stage I non-small cell lung cancer].
    Fukino S; Fukata T; Hayashi E; Okada K; Metsugi H; Miwa K; Morio S
    Kyobu Geka; 2002 Feb; 55(2):110-5. PubMed ID: 11842546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
    Huang GJ; Fang DK; Cheng GY; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
    Varlotto JM; Flickinger JC; Recht A; Nikolov MC; DeCamp MM
    Cancer; 2008 Apr; 112(7):1547-54. PubMed ID: 18260087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins.
    Ono K; Sugio K; Uramoto H; Baba T; Ichiki Y; Takenoyama M; Hanagiri T; Oyama T; Yasumoto K
    Cancer; 2009 Aug; 115(15):3489-500. PubMed ID: 19452548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
    Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
    Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical indication for non-small cell lung cancer with synchronous distant metastases].
    Hirose M; Ota S; Ishibashi H
    Kyobu Geka; 2006 Jan; 59(1):15-20. PubMed ID: 16440679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior and basal segment lung cancers in the lower lobe have different lymph node metastatic pathways and prognosis.
    Watanabe S; Suzuki K; Asamura H
    Ann Thorac Surg; 2008 Mar; 85(3):1026-31. PubMed ID: 18291191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.